News
Sanofi has scrapped its collaboration with IGM Biosciences, eliminating the biotech’s l | Sanofi has scrapped its ...
After losing its powerhouse partner, IGM Biosciences closed “most” of its labs and offices and initiated a strategic review ...
Novavax posts $667 million in Q1 2025 revenue and $2.93 EPS, boosted by Sanofi payments and APA terminations; full-year ...
Recursion said it earned its latest milestone payout by identifying differentiated, oral small molecule leads against a ...
Moody’s Ratings has upgraded the long-term issuer rating and senior unsecured ratings of Sanofi (NASDAQ:SNY) from A1 to Aa3.
Clinical Trials Arena on MSN2d
Sanofi exec tells biotechs not to scrimp on clinical trial designIt is vital for biotech companies to run the right clinical trial and not cut costs with trial design or patient recruitment, ...
Sanofi ends antibody partnership with IGM Biosciences, while Lilly extends Purdue University collaboration with $250M ...
Saudi Society of Dermatology and Sanofi Sign MoU to Advance Dermatological Care in Saudi Arabia ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback